Der allererste Cannabis Wert in Kanada!
Seite 15 von 60 Neuester Beitrag: 11.06.25 11:36 | ||||
| Eröffnet am: | 07.04.14 17:00 | von: Andrew6466 | Anzahl Beiträge: | 2.481 |
| Neuester Beitrag: | 11.06.25 11:36 | von: Highländer49 | Leser gesamt: | 780.988 |
| Forum: | Hot-Stocks | Leser heute: | 251 | |
| Bewertet mit: |  | |||
| Seite: < 1 | ... | 12 | 13 | 14 | | 16 | 17 | 18 | ... 60 > | ||||
Canopy Growth enters landmark research.....
https://ceo.ca/@newswire/...h-enters-landmark-research-and-production
SMITHS FALLS, ON and VICTORIA, Australia, Jan. 16, 2018 /CNW/ - Canopy Growth Corporation (TSX: WEED) ("Canopy Growth" or the "Company") and the Victorian State Government today announced the signing of a significant Memorandum of Understanding ("MOU") to further develop research and technical capabilities in the production of medical cannabis in Australia.
The Honourable Minister for Agriculture Jaala Pulford MLC officially announced the research collaboration this morning between Canopy Growth and Agriculture Victoria, the ministry of agriculture for the state government of Victoria, Australia. The work will focus on medical applications for cannabis genetics, strain development, cultivation, and processing. This partnership will directly contribute to the emerging medical cannabis industry in Australia, allowing for improved patient access in that market, creating a leadership position for Australia and Canopy Growth in the Asia Pacific geography.
As part of this agreement, stabilized cannabis genetics from Canopy Growth's Canadian operations have already been successfully imported into the country and are growing healthily in the state of Victoria.
"This agreement allows us to combine our expertise in medical cannabis with the world-leading bioscience research capabilities of Agriculture Victoria," said Mark Zekulin, President, Canopy Growth. "With this important MOU, we hope to increase innovation and institutional understanding in the Australian medical cannabis market to ensure that our globally recognized genetics are available in Australia for research and commercial purposes."
Victoria was the first state in Australia to legalize access to medical cannabis for patients in the region, and the State will use its prominent bioscience research capabilities in Agriculture Victoria to work with Canopy Growth to identify and develop optimal plant strains for a range of therapeutic uses. Specific capabilities include genome sequencing, comprehensive metabolome analysis and chemo-typing, as well as technologies for accelerated precision breeding.
Canopy Growth has quickly emerged from the Canadian market to establish itself as the world's largest cannabis company. Since 2014 it has operated under federal medical cannabis laws and serves over a third of the estimated medical cannabis patients in the country, more than 69,000 people. Canopy now operates in seven countries internationally and has driven the medical cannabis dialogue forward by engaging with medical professionals to educate them on the existing body of evidence surrounding cannabis. Canopy's network includes a partnership with partly-owned leading Australian cannabis company, AusCann Group Holdings ("AusCann"), based in Western Australia, who will directly benefit by being able to more readily access Canopy's base of genetics to advance its medical research initiatives and development.
"Working with global leaders like Canopy Growth on cultivation and production will build Victoria's capacity to develop an industry capable of supplying reliable and high quality medical cannabis products to treat a range of conditions in approved patients," said the Honourable Jaala Pulford, Minister for Agriculture, Victorian State Government.
The collaboration between an international industry-leader in the cultivation and value-add production of medical cannabis products like Canopy Growth and a globally recognized bioscience researcher in Agriculture Victoria is a major development for Australian cannabis market progression and shows strong leadership on the part of the Victoria Government. The products being developed through this MOU, as well as the recently imported genetics, will ensure that locally produced, high quality medical cannabis products are legally available to patients in the Australian market in the near future.
Here's to Future Growth (Down Under).
Read more at http://www.stockhouse.com/companies/bullboard#MoXoafkuEdMPBuHE.99
https://ceo.ca/@newswire/...h-enters-landmark-research-and-production
SMITHS FALLS, ON and VICTORIA, Australia, Jan. 16, 2018 /CNW/ - Canopy Growth Corporation (TSX: WEED) ("Canopy Growth" or the "Company") and the Victorian State Government today announced the signing of a significant Memorandum of Understanding ("MOU") to further develop research and technical capabilities in the production of medical cannabis in Australia.
The Honourable Minister for Agriculture Jaala Pulford MLC officially announced the research collaboration this morning between Canopy Growth and Agriculture Victoria, the ministry of agriculture for the state government of Victoria, Australia. The work will focus on medical applications for cannabis genetics, strain development, cultivation, and processing. This partnership will directly contribute to the emerging medical cannabis industry in Australia, allowing for improved patient access in that market, creating a leadership position for Australia and Canopy Growth in the Asia Pacific geography.
As part of this agreement, stabilized cannabis genetics from Canopy Growth's Canadian operations have already been successfully imported into the country and are growing healthily in the state of Victoria.
"This agreement allows us to combine our expertise in medical cannabis with the world-leading bioscience research capabilities of Agriculture Victoria," said Mark Zekulin, President, Canopy Growth. "With this important MOU, we hope to increase innovation and institutional understanding in the Australian medical cannabis market to ensure that our globally recognized genetics are available in Australia for research and commercial purposes."
Victoria was the first state in Australia to legalize access to medical cannabis for patients in the region, and the State will use its prominent bioscience research capabilities in Agriculture Victoria to work with Canopy Growth to identify and develop optimal plant strains for a range of therapeutic uses. Specific capabilities include genome sequencing, comprehensive metabolome analysis and chemo-typing, as well as technologies for accelerated precision breeding.
Canopy Growth has quickly emerged from the Canadian market to establish itself as the world's largest cannabis company. Since 2014 it has operated under federal medical cannabis laws and serves over a third of the estimated medical cannabis patients in the country, more than 69,000 people. Canopy now operates in seven countries internationally and has driven the medical cannabis dialogue forward by engaging with medical professionals to educate them on the existing body of evidence surrounding cannabis. Canopy's network includes a partnership with partly-owned leading Australian cannabis company, AusCann Group Holdings ("AusCann"), based in Western Australia, who will directly benefit by being able to more readily access Canopy's base of genetics to advance its medical research initiatives and development.
"Working with global leaders like Canopy Growth on cultivation and production will build Victoria's capacity to develop an industry capable of supplying reliable and high quality medical cannabis products to treat a range of conditions in approved patients," said the Honourable Jaala Pulford, Minister for Agriculture, Victorian State Government.
The collaboration between an international industry-leader in the cultivation and value-add production of medical cannabis products like Canopy Growth and a globally recognized bioscience researcher in Agriculture Victoria is a major development for Australian cannabis market progression and shows strong leadership on the part of the Victoria Government. The products being developed through this MOU, as well as the recently imported genetics, will ensure that locally produced, high quality medical cannabis products are legally available to patients in the Australian market in the near future.
Here's to Future Growth (Down Under).
Read more at http://www.stockhouse.com/companies/bullboard#MoXoafkuEdMPBuHE.99
Wieso notiert der Kurs in FRA eigentlich mit aktuell fast 5% im Minus, wenn der Schlusskurs in Kanada mit fast 3% im Plus lag? Panische deutsche Anleger?
Fand das auch komisch. Aber nach Weihnachten wurde hier noch erster Kurs 15,20 gehandelt, obwohl die Aktie in USA schon umgerechnet weit drüber lag. Manchmal ein Rätsel...
Wenn manche Leute unbedingt in DE raus wollen, dann können auch andere kurze als in Toronto aufgerufen werden. ..kann billiger oder teurer sein.
Nun ist der Kurs innerhalb von einer Woche von 25€ auf 15€ gefallen. Gab es negative Berichte, oder könnte es sich um Gewinnmitnahmen handeln? Ich überlege nämlich nachzukaufen. Weiß jemand mehr?
kann ich nicht finden. Aber warum fällt es so stark? Nur Gewinnmitnahmen können es nicht sein.
Ich überlege nun auch wieder nachzukaufen!
Ich überlege nun auch wieder nachzukaufen!
überlege genauso wie ihr...versteh es gerade auch nicht bzw hab nichts gelesen warum die Aktie so in die Knie geht!
Sollte 2020 sein. Zumindest wird doch ein deutlich und stetig wachsender Markt gesehen. Der Kursanstieg war Anfang Januar natürlich auch ziemlich heftig. Kann tatsächlich an Mitnahmen größerer Anleger sein. Aufgrund der Zinsentscheidung ist der Nasdaq heute auch tiefrot.
Was hier und auch weltweit aktuell für Kursschwankungen passieren. Einen Moment Minus 10% und kurz später Plus 10%. Wie es weitergeht, kann wohl niemand sagen.
Der Hype geht weiter. Bis zu Legalisierung von Cannabis in Kanada.
Keine kauf oder Verkaufs Empfehlung
Keine kauf oder Verkaufs Empfehlung
Ich hoffe mal das es heute wieder steigt. Naja bis Mitte des Jahres sollte ich ein schönen Gewinn realisiert haben.
Keine kauf oder Verkaufs Empfehlung
Keine kauf oder Verkaufs Empfehlung
Mal Richtung 15 Euro pro Aktie rutschen. Da würde ich dann meine bis jetzt kleine Posi mehr als verdoppeln. Es ist aber schwer zu beurteilen ob das wirklich passiert. Die Aktie ist auch um 20 % gestiegen als der Markt abgesackt ist. Verrückt dieses Teil:)
Keine kauf oder Verkaufs Empfehlung
Keine kauf oder Verkaufs Empfehlung
Auch Interesse an diesem artverwandten buisness haben. . ..."
3. Opens the door for other major company investments
Perhaps the the biggest impact of the Constellation-Canopy deal for marijuana stocks in general is that it could open the door for investments in marijuana stocks by other major companies. I have thought for quite a while that big tobacco companies could be eyeing the cannabis market. One of them could be especially paying attention to Constellation's latest move.
Altria (NYSE:MO) is one of the largest tobacco companies in the world but also owns a stake in Anheuser-Busch Inbev (NYSE:BUD), the largest beer maker in the world. If Constellation is planning to launch a cannabis-infused beer, Anheuser-Busch Inbev is probably thinking about it as well. And Altria could be also wondering if the time is right for expansion into what could become a significant consumer trend."
3. Opens the door for other major company investments
Perhaps the the biggest impact of the Constellation-Canopy deal for marijuana stocks in general is that it could open the door for investments in marijuana stocks by other major companies. I have thought for quite a while that big tobacco companies could be eyeing the cannabis market. One of them could be especially paying attention to Constellation's latest move.
Altria (NYSE:MO) is one of the largest tobacco companies in the world but also owns a stake in Anheuser-Busch Inbev (NYSE:BUD), the largest beer maker in the world. If Constellation is planning to launch a cannabis-infused beer, Anheuser-Busch Inbev is probably thinking about it as well. And Altria could be also wondering if the time is right for expansion into what could become a significant consumer trend."
die Legalisierung von Cannabis in Kanada meiner Meinung nach bald zu Ende sein. Außerdem könnten noch ein paar US Bundesstaaten dazu kommen. Könnte ich würde ich bei 17 Euro pro Aktie nachkaufen.
Keine kauf oder Verkaufs Empfehlung
Keine kauf oder Verkaufs Empfehlung
Canopy Growth obtains license for first mega-scale BC facility
https://web.tmxmoney.com/...ewsid=8225490418265108&qm_symbol=WEED
https://web.tmxmoney.com/...ewsid=8225490418265108&qm_symbol=WEED
Ich hoffe mal das wir bis Mitte des Jahres nochmal das ATH erreichen. Dann spring ich ab.
Keine Kauf- oder Verkaufsempfehlung
Keine Kauf- oder Verkaufsempfehlung
Was auch sonst?
Optionen
| Boardmail an "Humpty" |
Wertpapier: Canopy Growth Corp |